Cytotoxicity evaluation of iron nitride nanoparticles for biomedical applications.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33749145.
- Also identified by DOI 10.1002/jbm.a.37171.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Magnetic nanoparticles are widely studied for their use in various therapeutic and diagnostic purposes. As biomaterials, their biocompatibility is as important as their magnetic properties. Iron nitride (Fe<sub>x</sub> N<sub>y</sub> ) has excellent magnetic properties, and thus Fe<sub>x</sub> N<sub>y</sub> nanoparticles could be useful as potential biomaterials. However, the biocompatibility of Fe<sub>x</sub> N<sub>y</sub> nanoparticles is yet to be investigated. In this study, we assessed the biocompatibility of Fe<sub>x</sub> N<sub>y</sub> nanoparticles by evaluating their direct-contact cytotoxicity compared with that of magnetite nanoparticles (MNPs). Rat fibroblasts were incubated with the nanoparticle samples dispersed in culture medium at concentrations of 10, 50, and 100 μg/ml. The DNA concentration measurement, MTT assay, and trypan blue exclusion test were conducted after days 1 and 3 of incubation. After day 1, the cell viability decreased, and cell death increased with increasing sample concentration when compared with the control. However, after day 3, there were no significant differences when compared with the control, irrespective of the sample concentrations. Further, there were no significant differences between the Fe<sub>x</sub> N<sub>y</sub> nanoparticles and MNPs at the same concentrations in all the cytotoxicity evaluation tests. Therefore, it is suggested that Fe<sub>x</sub> N<sub>y</sub> nanoparticles might be as cytocompatible as the conventional MNPs.
Medical subject headings
- Biomedical Technology
- Iron
- Iron Compounds
- Nanoparticles